jonitown Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the company") held its fourth meeting on September 15, 2020 The 23rd session of the board of directors deliberated and passed the regulation on repurchase of company's shares by means of centralized competitive price trading On September 17, 2020, Jiuzhoutong's proposal on repurchasing the company's shares through centralized competitive trading was disclosed The company plans to buy back part of the company's shares through centralized competitive trading with its own funds The total amount of purchase funds shall not be less than 300 million yuan, not more than 600 million yuan, and the price of repurchase shares shall not exceed 26.80 million yuan The buyback period shall not exceed 6 months from the date when the board of directors deliberates and approves the final plan of stock buyback. Details See the website of Shanghai Stock Exchange on September 16, 2020 and September 17, 2020